The use of RC-529 as an adjunct improves the efficacy of recombinant hepatitis B vaccine

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1321, 2002-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

SBAS4 adjuvant improves efficacy of hepatitis B vaccine

By  

Inpharma, Vol. 1, Iss. 1241, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Recombinant Hepatitis B Vaccine (Engerix-B®): A Review of its Immunogenicity and Protective Efficacy Against Hepatitis B

By Keating G.M.   Noble S.  

Drugs, Vol. 63, Iss. 10, 2003-01 ,pp. : 1021-1051

Adis International

Access to resources Recommend Favorite

Hepatitis B vaccine recombinant: Lack of efficacy in prevention of hepatitis B: case report

By  

Reactions Weekly, Vol. 1, Iss. 1347, 2011-01 ,pp. : 22-23

Adis International

Access to resources Recommend Favorite

Recombinant hepatitis B vaccine provides rapid seroprotection

By  

Inpharma, Vol. 1, Iss. 1277, 2001-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Increase use of thiomersal-free hepatitis B vaccine

By  

Inpharma, Vol. 1, Iss. 1284, 2001-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite